DISEASE INDICATIONS: Sickle Cell Disease

MANUFACTURER: Novartis

USAGE: Intravenous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Adakveo is a medication used to manage sickle cell disease and reduce the frequency of vaso-occlusive crises in patients 16 and older.